Investigators evaluated the activity of pembrolizumab in classic and endemic Kaposi sarcoma with cutaneous extension requiring systemic treatment.
[Lancet Oncology]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.